Ignite Creation Date:
2025-12-25 @ 12:12 AM
Ignite Modification Date:
2026-02-19 @ 3:17 AM
Study NCT ID:
NCT02750358
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-06-22
First Post:
2016-04-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Feasibility Study of Adjuvant Enzalutamide for the Treatment of Early Stage AR (+) Triple Negative Breast Cancer
Sponsor:
Organization: